Home › Funds › NAN FUNG TRINITY (HK) Ltd › ABEO

NAN FUNG TRINITY (HK) Ltd position in ABEO

ABEONA THERAPEUTICS INC · Health Care

NAN FUNG TRINITY (HK) Ltd reported holding 956,770 shares of ABEO (ABEONA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$5.9M, representing 0.58% of its reported portfolio and ranking #46 among its reported holdings. NAN FUNG TRINITY (HK) Ltd has disclosed ABEO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)956.77K sh
Reported value held$5.91M
Portfolio Weight0.58%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NAN FUNG TRINITY (HK) Ltd's ABEO position evolved

NAN FUNG TRINITY (HK) Ltd first disclosed a stake in ABEO in Q2 2025 at 560,770 shares (US$3.2M). The position peaked in Q2 2026 at 956,770 shares, worth US$5.9M. Across 5 filings, NAN FUNG TRINITY (HK) Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 956,770 shares valued at US$5.9M. Notable position changes include a 71% increase in Q4 2025 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 560.77K $3.19M New
Q3 2025 560.77K $2.96M Hold
Q4 2025 956.77K $5.04M Add
Q1 2026 956.77K $4.29M Hold
Q2 2026 956.77K $5.91M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABEO and 13F data

ABEO (ABEONA THERAPEUTICS INC) is a Health Care company. 38 other funds we track also report a position in ABEO — the largest reported positions include Cable Car Capital, LP (US$18.6M), AIGH Capital Management LLC (US$18.5M), AWM Investment Company, Inc. (US$9.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABEO

All ABEO fund holders →

FAQ

How long has NAN FUNG TRINITY (HK) Ltd held ABEO?

NAN FUNG TRINITY (HK) Ltd has disclosed ABEO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is NAN FUNG TRINITY (HK) Ltd's current position in ABEO?

As of Q2 2026, NAN FUNG TRINITY (HK) Ltd holds 956.77K shares of ABEO (ABEONA THERAPEUTICS INC), valued at $5.91M, representing 0.58% of its reported portfolio and ranking #46.

Has NAN FUNG TRINITY (HK) Ltd been buying or selling ABEO?

In the latest 13F filing (Q2 2026), NAN FUNG TRINITY (HK) Ltd held unchanged its position in ABEO. The position peaked in Q2 2026 at 956.77K shares.

Which other funds hold ABEO?

Other major institutional holders of ABEO include Cable Car Capital, LP, AIGH Capital Management LLC, AWM Investment Company, Inc., among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.